209 related articles for article (PubMed ID: 19233263)
1. Protein kinase CK2 interacts with adiponectin receptor 1 and participates in adiponectin signaling.
Heiker JT; Wottawah CM; Juhl C; Kosel D; Mörl K; Beck-Sickinger AG
Cell Signal; 2009 Jun; 21(6):936-42. PubMed ID: 19233263
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation of Nrf2 in the transcription activation domain by casein kinase 2 (CK2) is critical for the nuclear translocation and transcription activation function of Nrf2 in IMR-32 neuroblastoma cells.
Apopa PL; He X; Ma Q
J Biochem Mol Toxicol; 2008 Feb; 22(1):63-76. PubMed ID: 18273910
[TBL] [Abstract][Full Text] [Related]
3. Supervision of multiple signaling protein kinases by the CK2-Cdc37 couple, a possible novel cancer therapeutic target.
Miyata Y; Nishida E
Ann N Y Acad Sci; 2004 Dec; 1030():150-7. PubMed ID: 15659792
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C virus NS2 protein is phosphorylated by the protein kinase CK2 and targeted for degradation to the proteasome.
Franck N; Le Seyec J; Guguen-Guillouzo C; Erdtmann L
J Virol; 2005 Mar; 79(5):2700-8. PubMed ID: 15708989
[TBL] [Abstract][Full Text] [Related]
5. Protein kinase CK2 interacts with the splicing factor hPrp3p.
Lehnert S; Götz C; Kartarius S; Schäfer B; Montenarh M
Oncogene; 2008 Apr; 27(17):2390-400. PubMed ID: 18026141
[TBL] [Abstract][Full Text] [Related]
6. Protein kinase CK2 activates the atypical Rio1p kinase and promotes its cell-cycle phase-dependent degradation in yeast.
Angermayr M; Hochleitner E; Lottspeich F; Bandlow W
FEBS J; 2007 Sep; 274(17):4654-67. PubMed ID: 17725716
[TBL] [Abstract][Full Text] [Related]
7. Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions.
Yamauchi T; Nio Y; Maki T; Kobayashi M; Takazawa T; Iwabu M; Okada-Iwabu M; Kawamoto S; Kubota N; Kubota T; Ito Y; Kamon J; Tsuchida A; Kumagai K; Kozono H; Hada Y; Ogata H; Tokuyama K; Tsunoda M; Ide T; Murakami K; Awazawa M; Takamoto I; Froguel P; Hara K; Tobe K; Nagai R; Ueki K; Kadowaki T
Nat Med; 2007 Mar; 13(3):332-9. PubMed ID: 17268472
[TBL] [Abstract][Full Text] [Related]
8. CK2 Is a component of the KSR1 scaffold complex that contributes to Raf kinase activation.
Ritt DA; Zhou M; Conrads TP; Veenstra TD; Copeland TD; Morrison DK
Curr Biol; 2007 Jan; 17(2):179-84. PubMed ID: 17174095
[TBL] [Abstract][Full Text] [Related]
9. HIRIP3 is a nuclear phosphoprotein interacting with and phosphorylated by the serine-threonine kinase CK2.
Assrir N; Filhol O; Galisson F; Lipinski M
Biol Chem; 2007 Apr; 388(4):391-8. PubMed ID: 17391060
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylation by casein kinase 2 induces PACS-1 binding of nephrocystin and targeting to cilia.
Schermer B; Höpker K; Omran H; Ghenoiu C; Fliegauf M; Fekete A; Horvath J; Köttgen M; Hackl M; Zschiedrich S; Huber TB; Kramer-Zucker A; Zentgraf H; Blaukat A; Walz G; Benzing T
EMBO J; 2005 Dec; 24(24):4415-24. PubMed ID: 16308564
[TBL] [Abstract][Full Text] [Related]
11. Sic1 is phosphorylated by CK2 on Ser201 in budding yeast cells.
Coccetti P; Zinzalla V; Tedeschi G; Russo GL; Fantinato S; Marin O; Pinna LA; Vanoni M; Alberghina L
Biochem Biophys Res Commun; 2006 Aug; 346(3):786-93. PubMed ID: 16777072
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation of apolipoprotein-E at an atypical protein kinase CK2 PSD/E site in vitro.
Raftery M; Campbell R; Glaros EN; Rye KA; Halliday GM; Jessup W; Garner B
Biochemistry; 2005 May; 44(19):7346-53. PubMed ID: 15882073
[TBL] [Abstract][Full Text] [Related]
13. RGSZ1 interacts with protein kinase C interacting protein PKCI-1 and modulates mu opioid receptor signaling.
Ajit SK; Ramineni S; Edris W; Hunt RA; Hum WT; Hepler JR; Young KH
Cell Signal; 2007 Apr; 19(4):723-30. PubMed ID: 17126529
[TBL] [Abstract][Full Text] [Related]
14. The CK2 alpha/CK2 beta interface of human protein kinase CK2 harbors a binding pocket for small molecules.
Raaf J; Brunstein E; Issinger OG; Niefind K
Chem Biol; 2008 Feb; 15(2):111-7. PubMed ID: 18291315
[TBL] [Abstract][Full Text] [Related]
15. Optimization of protein kinase CK2 inhibitors derived from 4,5,6,7-tetrabromobenzimidazole.
Pagano MA; Andrzejewska M; Ruzzene M; Sarno S; Cesaro L; Bain J; Elliott M; Meggio F; Kazimierczuk Z; Pinna LA
J Med Chem; 2004 Dec; 47(25):6239-47. PubMed ID: 15566294
[TBL] [Abstract][Full Text] [Related]
16. [Screening ubiquitin/ribosomal protein S27a by yeast two-hybridization system].
Huang GH; Liang JY; Chen B; Liu XG; Liang NC
Ai Zheng; 2005 Jan; 24(1):40-6. PubMed ID: 15642198
[TBL] [Abstract][Full Text] [Related]
17. A novel protein kinase CK2 substrate indicates CK2 is not directly stimulated by polyamines in vivo.
Lawson K; Larentowicz L; Artim S; Hayes CS; Gilmour SK
Biochemistry; 2006 Feb; 45(5):1499-510. PubMed ID: 16445292
[TBL] [Abstract][Full Text] [Related]
18. 2-Dimethylamino-4,5,6,7-tetrabromo-1H-benzimidazole: a novel powerful and selective inhibitor of protein kinase CK2.
Pagano MA; Meggio F; Ruzzene M; Andrzejewska M; Kazimierczuk Z; Pinna LA
Biochem Biophys Res Commun; 2004 Sep; 321(4):1040-4. PubMed ID: 15358133
[TBL] [Abstract][Full Text] [Related]
19. Discrimination between the activity of protein kinase CK2 holoenzyme and its catalytic subunits.
Salvi M; Sarno S; Marin O; Meggio F; Itarte E; Pinna LA
FEBS Lett; 2006 Jul; 580(16):3948-52. PubMed ID: 16806200
[TBL] [Abstract][Full Text] [Related]
20. Adipokines regulate systemic insulin sensitivity in accordance to existing energy reserves.
Huypens P
Med Hypotheses; 2007; 69(1):161-5. PubMed ID: 17208384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
